Avalo Therapeutics, Inc. · NASDAQ:AVTX

Avalo Therapeutics, Inc. insider trades

Avalo Therapeutics, Inc.'s insiders made 0 buys and 40 sales on the open market in the last 12 months. Each trade with the insider, role, price and filing.

DateInsiderTradeSharesPriceFiling
Sep 16, 2026Sullivan Christopher RyanSale12,394US$16Form 4
Sep 10, 2026Sullivan Christopher RyanSale10,185US$18Form 4
Aug 28, 2026Doyle MittieSale679US$20Form 4
Aug 18, 2026Sullivan Christopher RyanSale31,031US$20Form 4
Aug 17, 2026Sullivan Christopher RyanSale3,749US$20Form 4
Aug 17, 2026Sullivan Christopher RyanSale37,945US$20Form 4
Aug 17, 2026Doyle MittieSale1,000US$20Form 4
Aug 11, 2026Riley JenniferSale2,655US$20Form 4
Aug 10, 2026Doyle MittieSale679US$20Form 4
Jul 27, 2026Doyle MittieSale1,000US$20Form 4

Avalo Therapeutics, Inc. shareholders